Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia

NCT00391560 is registered in ClinicalTrials.gov with AEterna Zentaris as lead sponsor.

NCT NCT00391560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00391560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
Lead sponsor
AEterna Zentaris
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2006
Completion date
October 31, 2011
Enrollment
19 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia